Summary: N-Acetyl-aspartate (NAA) is almost exclu sively localized in neurons in the mature brain and might be used as a neuronal marker. It has been reported that the NAA content in human brain is decreased in neuro degenerative diseases and in stroke. Since the NAA con tent can be determined by nuclear magnetic resonance techniques, it has potential as a diagnostic and prognostic marker. The objective of this study was to examine the change of NAA content and related substances following cerebral ischemia and compare the results to the damage of the tissue. We used rats to study the changes of NAA, N-acetyl-aspartyl-glutamate (NAAG), glutamate, and as partate contents over a time course of 24 h in brain re gions affected by either permanent middle cerebral artery occlusion (focal ischemia) or decapitation (global isch emia). The decreases of NAA and NAAG contents fol lowing global brain ischemia were linear over time but significant only after 4 and 2 h, respectively. After 24 h, the levels of N AA and N AAG were 24 and 44% of control values, respectively. The concentration of glutamate did not change, whereas the aspartate content increased at a rate comparable with the rate of decrease of N AA con tent. This is consistent with NAA being preferentially degraded by the enzyme amidohydrolase II in global isch-
emia. In focal ischemia, there was a rapid decline of NAA within the first 8 h of ischemia followed by a slower rate of reduction. The reductions of NAA and NAAG con tents in focal ischemia were significant after 4 and 24 h, respectively. After 24 h, the NAA and NAAG contents were 33 and 64% of control values, respectively. Also, the glutamate and aspartate contents exhibited significant decreases in focal ischemic tissue. Our studies show that NAA decreases during brain ischemia, the initial rate be ing faster in focal ischemia than in global ischemia. In rat transient focal ischemia, others have shown that a middle cerebral artery occlusion of 2-to 3-h duration is sufficient to produc� an infarct that is similar in size to that follow ing permanent occlusion for 24 h. The fact that we ob served only a 10% decrease of NAA content 2 h after occlusion demonstrates that the NAA content of the tis sue does not reflect neuronal viability. Thus, the incom petence with which ischemic/infarcted tissue removes NAA will lead to overestimation of the number of viable neurons in acute situations. Only when steady state pre vails may [NAA] be used as a marker of viable nerve cells. Key Words: N-Acetyl-aspartate-Amino acids Focal ischemia-Global ischemia-High performance liq uid chromatography.
rect measure of infarct size; furthermore, no spatial information is obtained. N-Acetyl-aspartate (NAA) is located primarily in neurons of the mature CNS, and its concentration is in the millimolar range (Tal Ian et aI., 1956; Nadler and Cooper, 1972; Urenjak et aI., 1992 Urenjak et aI., , 1993 . NAA can be detected noninva sively by IH-nuclear magnetic resonance (NMR) spectroscopy, and the tissue concentration may therefore be used as an in vivo measure of neuronal density. Recent noninvasive in vivo NMR spectros copy measurements in stroke patients have sho�n that the level of NAA is severely reduced in the affected regions (Gideon et aI., 1992; Graham et al. , 1992; Hugg et aI., 1992; Petroff et aI., 1992) . A de crease in NAA content has also been demonstrated in neuronal diseases like Huntington's disease (Dunlop et al., 1992) , amyotrophic lateral sclerosis (Rothstein et aI., 1990; Plaitakis and Constan takakis, 1993; Tsai et aI., 1993) and following HIV infection of the CN S (Meyerhoff et al., 1993) .
To evaluate the potential of the NAA level as an indicator of neuronal damage, we measured the time course of changes in brain N AA content and of N-acetyl-aspartyl-glutamate ( N AAG), glutamate, and aspartate concentrations in focal and global ce rebral ischemia.
METHODS

Focal ischemia
Forty-eight adult male Wi star rats (250-350 g) were studied. Anesthesia was induced in a glass chamber with 3% halothane in oxygen followed by endotracheal intu bation. The rats were mechanically ventilated with N201 O2 (0.4:0.2 Llmin) in 1.5% halothane. Rectal temperature was monitored and kept at 37 ± O.soC with a heating pad. A polyethylene catheter was placed in the tail artery for blood pressure measurement and blood sampling. Arte rial blood gases and pH were measured regularly and P aco2 kept between 4.5 and 6 kPa. A temperature probe placed on the tympanic membrane served as a measure for the brain temperature. We used the technique de scribed by Tamura et al. (1981) to produce middle cere bral artery occlusion (MCAO). After operation, anesthe sia was discontinued and the rats were allowed to breathe spontaneously in a chamber at �30°C. When they started to move, they were placed in individual cages. After se lected time periods [0.25 h (n = 7), 2 h (n = 8), 4 h (n = 8), 8 h (n = 7), and 24 h (n = 9)], the rats were reanes thetized (Mebumal, 50 mg/kg i.p.) and the head secured in a stereotaxic frame. A 27G needle attached to a I-ml sy ringe was carefully positioned into the cisterna magna through the atlantic-occipital membrane, and 100-200 f,L1 CSF was collected. An additional nine rats were used to measure the basal CSF level of the metabolites. Samples discolored by blood were discarded. Subse quently, the rats were placed in the supine position, the thorax was opened, and l.5 ml saline containing 2% Mal achite green was infused through the left ventricle to vi sualize the MCA territory. After 30 s, the brains were removed, frozen on powdered dry ice, and stored at -80°C. Seven sham-operated rats served as controls. The sham-operated rats underwent the same operational procedure as the occluded rats except for the MCAO.
Tissue specimens were obtained as follows: The frozen brains were kept at room temperature for 3 min before being cut coronally using razor blades through the middle of the region lacking Malachite green staining. The ante rior half of the brain was used for measurement of me tabolite content and the posterior for histological exami nation. Ten-micron-thick frozen sections were stained with hematoxylin-eosin. Microscopic examination en abled us to locate the ischemic and infarcted brain re gions, which were removed from the corresponding brain part for measurements of NAA, NAAG, glutamate, and aspartate. The corresponding regions from the opposite hemisphere served as controls. In rats (sham operated and 0.25-h ischemic rats) showing no histological changes 
Stability of NAA during preparation
To examine whether 3 min of thawing and subsequent sampling of ischemic tissue (total time: 8-10 min) pro duces a decrease in [NAA], we decapitated four rats. The brains were removed and cut into 12 parts that were cov ered with aluminum foil and kept at 21°C. At times 0, to, 20,40,80, and 160 min, two tissue samples were prepared as described and [NAA] determined.
Basal concentrations
The basal [NAA] and [NAAG] were measured in whole brains of nine rats. The basal concentrations of glutamate and aspartate were measured in whole forebrains of three rats. The tissue was prepared as described later on.
Global brain ischemia
Eighteen rats were decapitated without prior anesthe sia. The heads were wrapped in aluminum foil and placed in a 37"C chamber for 0, I, 2, 4, 8, and 24 h (n = 3 for all groups). The brains were removed and the forebrains were prepared as described herein.
Ethics
The experimental protocol followed the guidelines ap proved by the local ethics committee for animal research.
Tissue preparation
The extraction of metabolites was performed by a mod ified version as described by Plaitakis and Constantakakis (1993) . Tissue samples (30-60 mg focal ischemic tissue) were dissolved in 0.1 M perchloric acid and homogenized by a Branson Sonifier Cell Disrupter while cooled in ice water. The homogenates were centrifuged at 20, 000 g in to min at 4°C. The supernatants were injected through a 0.22-f,Lm Millipore filter in HPLC vials. CSF samples were directly passed onto the HPLC columns.
HPLC parameters for metabolite quantitation
NAA and NAAG The HPLC method first described by Koller et al. (1984) was used for NAA and NAAG deter mination with some modifications. The mobile phase con sisted of 900 ml filtered water (Millipore) + 20 ml 5 M H3P04 + 5 M KOH (pH 4.5); l.875 giL KCI and distilled H20 were added up to I L. The mobile phase was filtered and degassed before being combined with the HPLC sys tem. This phase was continually degassed by helium to improve the baseline of the assay. The injection volume of the samples was 20 f,Ll and the flow rate 2 mllmin. A Whatman Partisil-IO SAX anion exchange column was used to separate metabolites. A LiChroSorb Si 60 satu ration column was placed before the exchange column to saturate the mobile phase with silica particles. NAA and NAAG were detected at 214 nm by a Merck-Hitachi L-4200 UV detector.
Glutamate and aspartate Estimation of the glutamate and aspartate contents was performed by HPLC using fluorescence detection (excitation: 330 nm; emission: 420 nm). The flow rate was 0.5 mllmin. Separation of sub stances was achieved using a gradient elution profile [buffer A: 800 ml phosphate buffer (pH 7.0) + 150 ml methanol + 25 ml tetrahydrofuran; buffer B: 200 ml H20 + 800 ml methanol]. Glutamate and aspartate were mea-sured as fluorescent derivates after a pre column o-phthal dialdehyde (OPA) derivazation. The OPA/BME reagent was prepared 24 h before use: 27 mg OPA dissolved in J ml methanol + 20 jJ-I l3-mercaptoethanol (BME) (Fluka 63690), and finalIy borate buffer (pH 9.2) up to 10 ml was added.
For analysis of glutamate and aspartate content, we used a 3-jJ-m Supelcosil LC-JS-DB column and a Merck F -1050 fluorescence detector. Both procedures were con trolled by a CMA/200 autosampling system. A Merck Hitachi D-2500 Chromato Integrator was used for peak quantitation. A Merck-Hitachi L-6000A pump, a Merck Hitachi T-6300 column thermostat, and a CMA-2000 re frigerated (4°C) autosampler were used.
Statistics
AlI data are presented as means ± SD. Analysis of variance, with subsequent Bonferroni/Dunn mUltiple comparison tests, was used to compare the data between time points. Based on the Bonferroni/Dunn mUltiple com parison test, a p value below 0.0033 was required for significance. The relative differences (ischemic/contra lateral) for focal ischemic samples were compared with the relative differences for sham-operated rats. AlI other data were analyzed in absolute values and compared with the values at t = O.
RESULTS
There was no significant difference at any time among the rat groups for variables measured, i. e. , rectal and tympanic temperature, arterial Pao2, Paco2, pH, and MABP (data not shown).
Stability of metabolites in brain sections
The brain NAA level steadily decreased at room temperature ( Fig. 1) . At 160 min, the decrease in [NAA] was significant (20% decrease). Glutamate and aspartate remain stable in postmortem brain tis sue for at least 4 h at 35°C (Perry et aI. , 1981) . Hence, our sampling procedure that lasted � 10 min provided a reliable measure of these metabolites in brain tissue.
Metabolite changes during focal cerebral ischemia
The control whole-brain concentrations of NAA and NAAG were 7. 15 ± 0. 28 and 0.26 ± 0.02 mmoll kg wet wt, respectively (n = 9), in agreement with other measurements in rat brain (D' Arcangelo et aI. , 1968; Burri et aI. , 1990; D'Arcangelo and Bran cati, 1990) . Control glutamate and aspartate con centrations were 10.60 ± 1.73 and 3. 32 ± 0.46 mmollkg wet wt, respectively, in whole forebrain (n There was a decrease of [NAA] in the ipsilateral corticostriatal tissue compared with the contralat eral side after 4, 8, and 24 h of ischemia (p < 0.001) (Fig. 2) . The rate of decline was more rapid during the first 8 h than during the next 16 h. After 24 h, the N AA level was 33% of the level of the contralateral hemisphere.
The reduction of [NAAG] after MCAO was less pronounced. The reduction of [NAAG] was signif icant first after 24 h (p = 0.0004), at which time the level was 64% of the contralateral hemisphere.
The changes of glutamate and aspartate are also shown in Fig. 2 . After 2 h, there was a significant decrease in [aspartate] (p = 0.0004), which was maintained throughout the period. The decrease in [glutamate] was significant after 8 h (p = 0.0019) and maintained throughout the period.
Metabolite changes in global brain ischemia
The declines of [NAA] and [NAAG] in rat fore brains kept at 37°C are shown in Fig. 3 . The pat terns of decrease were very similar for the two com pounds. The decrease of [NAA] was significant af ter 4 h of global ischemia (p = 0.0006), and after 24 h, the [NAA] had declined from 7 to 2 mmollkg wet wt. The [NAAG] was significantly decreased after 2 h (p = 0.0014).
Levels of glutamate did not change during the 24 h (Fig. 3) . The aspartate level, however, increased during the whole period (see Fig. 3 ) and was dou bled after 24 h (from the initial value of 3. 3 to 7.3 mmol/kg wet wt) (p = 0.0047).
Metabolite changes in CSF
The [NAA], [glutamate] , and [aspartate] in CSF of control rats (n = 9) were 16.6 ± 3. 1, 1. 53 ± 0.41, and 0.95 ± 0.39 j.LmoI/L, respectively, whereas the [NAAG] was below the detection limit of 1.0 j.Lmoll L. The level of [NAA] in CSF is in the same range as data obtained from humans (Rothstein et aI., 1990) , even though basal levels below 2.1 /-Lmol/L in humans have also been reported (K vittingen et aI., 1986) . The CSF concentrations of glutamate and as partate are in accordance with data obtained in rats by Phillis and Waiter (1989) 
Histology in focal ischemia
Sham-operated rats and rats exposed to 0.25 h of ischemia showed no histological damage in the right MCA territory, i.e., in piriform, insular, and pari etal cerebral cortex and lateral part of striatum. Af ter 2 h of ischemia, the affected areas were swollen, but the cellular structure was preserved. At 4 h of ischemia, there was an incipient eosinophilia of the neurons. Eight hours of ischemia produced numer ous eosinophilic neurons containing vacuoles, and the edema was pronounced. After 24 h of ischemia, a pronounced eosinophilic staining of nerve cells could be seen and the neurons became triangular in shape. The neuronal nucleus was condensed and basophilic. The neuropil was no longer preserved, and polymorphonuclear granulocytes could be seen. Time (hours) 
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DISCUSSION
Despite the fact that the NAA concentration is several millimolar in the brain, its function has re mained elusive and its metabolism is only partly understood (see Birken and Oldendorf, 1989) . NAA is present in minute amounts outside the CNS, and it does not easily cross the blood-brain barrier (BBB) (Berlinguet and Laliberte, 1966) . Synthesis occurs de novo in brain from acetyl-CoA and aspar tate (Burri et aI., 1991) or from NAAG (Robinson et aI., 1985) , the former being the more important route. In the mature brain, NAA is located mainly in neurons, whereas the immature brain also has a glial pool (Nadler and Cooper, 1972; Urenjak et aI., 1992 Urenjak et aI., , 1993 . The latter seems to be important in myelinogenesis (Tallan, 1957; Burri et aI., 199 1; Hida et aI., 1992) .
NAA in normal brain
The intraneuronal [NAA] may be calculated from knowledge of the N AA level in different brain com partments as well as their individual sizes. The in terstitial space occupies -20% of the brain tissue, and we assume that the [NAA] in the interstitial space is of a similar level as in CSF. The glial com partment occupies also -20% of the brains in small animals (Williams et aI., 1980) . Thus, the nerve cells constitute more than half of the brain tissue ' . The concentration of N AA in nerve cells can therefore be estimated to be 12 mmol/kg (7. 15/0.6), which is in agreement with the data of Urenjak et ai. (1992, 1993), who found [NAA] in neurons of primary cul tures to be 10.2-12.4 mmollkg (using HPLC and NMR techniques). This shows that nerve cells are able to maintain a 1,000-fold gradient of N AA across the cell membrane. Whether this is accom plished by high rates of synthesis, low cell mem brane permeability, or high membrane transport ac tivity is at present unknown.
NAA during brain ischemia
The decrease in NAA can in principle take place by removal via transport mechanisms or by conver sion (i.e., degradation). To determine the impor tance of these processes, we used isolated heads in which removal by transport is prevented. In these brains, [NAA] decreased at an almost linear rate of 0.2 mmollkg/h accompanied by a corresponding in crease of [aspartate] at a rate of 0. 17 mmol/kg/h. As NAA is a very stable compound in solution, the results strongly suggest that during proper brain ischemia, NAA is preferentially metabolized by the enzyme amidohydrolase II to aspartate and acetate. A slow decrease of [NAA] with a corresponding rise in [aspartate] was also observed by D' Arcan gelo et al. (1968) in rat brains stored at 3°C (0.12 mmollkg/h for both compounds during the first 24 h).
The rate of NAA loss (degradation) in our study is � 10 times slower than the amidohydrolase II ac tivity measured in vitro by Goldstein (1976) and Woiler and D'Adamo (1971) kg/h, respectively. Since NAA disappears more rapidly from brain homogenates than from intact brains (Goldstein, 1959; Jacobson, 1959; Bruns et aI., 1967) , brain amidohydrolase II may be located in a different cellular compartment than NAA or may be inhibited under normal conditions. Conver sion of NAA to NAAG is probably of little signifi cance since the content of NAAG also decreased and, after 24 h, reached 44% of the control value.
In focal ischemia, the rate of decline of [NAA] was initially faster than in global brain ischemia. During the first 4 h, the rate of loss was �0.47 mmol/kg/h compared with 0.20 mmollkg/h in global brain ischemia. Several explanations may be of fered. The fact that the normal intracellular concen tration is 1,000 times higher than the interstitial con centration means that the cellular content is re leased during ischemia and hence NAA could be removed via the CSF, as seen in patients with amy otrophic lateral sclerosis (Rothstein et aI., 1990) , and/or by the remaining blood flow. The first pos sibility is probably of little importance since no in crease of [NAA] in CSF was measured. Likewise, clearance via the blood may not be important since the BBB permeability to NAA is low (Berlinguet and Laliberte, 1966) , and the BBB permeability of low molecular substances remains low in the initial 3 h following MCAO (Betz et aI., 1994) . The regions involved in focal ischemia have a trickle of blood flow, which is insufficient to maintain the oxidative metabolism but may promote the production of free radicals and other active metabolites. This could explain the higher rate of degradation of NAA in focal ischemia because the brain cells are disinte grating faster, thereby bringing NAA and amidohy drolase II together. Another possibility could be that inhibition of the enzyme is removed or that necessary enzymatic cofactors become available.
In Garcia et al. (1978) . Our results indicate that [aspartate] and to a lesser extent [glutamate] de crease more rapidly from the ischemic tissue than [NAA] . Whether this is accomplished by degrada tion/combustion or removal by transport is un known. The fact that interstitial concentrations of glutamate and aspartate are increased following MCAO (Hagberg et aI., 1985) shows that cells re lease these substances, and the possibility exists that the metabolites may be removed by oiffusion or by clearance via the blood. Preliminary data using microdialysis show that NAA is indeed released from brain cells during ischemia and subsequently taken up during reperfusion (data not shown). The mechanism of release and uptake, however, is un identified.
NAA and histology in focal ischemia
The permanent occlusion of the MCA gives rise to infarcts clearly visible after 4-6 h in the lateral part of the striatum and most of the frontoparietal cortex of the MCA territory. As expected, the tis sue bound to become infarcted was not clearly de fined in rats 0.25 and 2 h after occlusion. In these cases, we sampled tissue that corresponded to the infarcted tissue in animals that survived for >2 h. Tissue constituents are probably diluted by the ischemic edema, but since water content in this model increases by 5-6% at the most (Dickinson and Betz, 1992) , the dilution error is small.
The key question is whether [NAA] in brain tis sue can be used as an indicator of viable nerve cells. Several NMR studies on stroke patients have shown that NAA could not be detected several days after ictus (Bruhn et aI., 1989; Gideon et aI., 1992; Graham et aI., 1992 Graham et aI., , 1993 , strongly suggesting that NAA can be used as a marker for nerve cell death. In our study, and as shown in a recent investigation by Monsein et ai. (1993) on baboons using NMR spectroscopy, [NAA] was near normal level 2 h postocclusion but significantly decreased after 4 h and continued to decline for the next 20 h. Transient MCAO with a duration of 0.5-6 h followed by re circulation for 7 days (Memezawa et aI., 1992) showed that the infarct reached its final size after 2-3 h of occlusion. Occlusions of 0.5 and I h re sulted in infarct volumes of 15 and 70%, respec tively, of the final size (Memezawa et aI., 1992) . Likewise, Kaplan et ai. (1991) found that the neo cortical infarct size after 1 and 2 h of transient isch emia was 10 and 45% of the maximum infarct size. We observed that 2 h postocclusion, [NAA] de creased only 10% at a time when most of the tissue was bound to become infarcted. There was a de crease of only 21% in [NAA] after 4 h of global brain ischemia at a time point when it is unlikely that 80% of the nerve cells could have survived. This means that the level of [ N AA] under these circumstances, i.e., acute situations, does not ap pear to express the number of viable neurons. How ever, it does not invalidate the use of NAA as a neuronal marker in the clinical evaluation of stroke patients. First, we have shown that the rate of deg radation of NAA is rather slow, and hence the level of NAA in the tissue becomes critically dependent upon removal of NAA released from dying neurons. After some days, however, we would envisage that NAA is completely removed since no nerve cells survive. In this situation, the level of NAA would reliably reflect the extent of neuronal damage. Sec ond, in vivo 'H-NMR spectroscopy determinations of NAA are based on the detection of free, mobile methyl groups in the N-acetyl head group. The in vivo NMR invisibility ofNAA might decrease more (or less) rapidly than the true NAA concentration, if the molecular environment of NAA became more (or less) supportive of rapid magnetic relaxation. Alternatively, sophisticated NMR spectroscopy techniques might be capable of discerning different environments for NAA during the time course of ischemic injury. In any case, the discrepancy be tween the level of NAA and the number of viable nerve cells is probably a reflection of the slow re moval due to long diffusion distances and low clear ance via the blood. Thus, the delayed escape of NAA from ischemic, hypoperfused tissue will over estimate the amount of NAA present in viable neu rons. Only situations in which a steady state pre vails between neuronal damage and [NAA] of the tissue may [NAA] be used as a reliable diagnostic and prognostic measure.
